Oral contraceptives and neoplasms other than breast and female genital tract

Carlo L. Vecchia, Cristina Bosetti

Research output: Contribution to journalArticlepeer-review


We reviewed epidemiological data on oral contraceptive (OC) use and colorectal, liver, lung and other nonfemale neoplasms. The data for colorectal cancer are suggestive of a favourable effect of OC, in the absence, however, of any duration-risk relation. Current, but not past, OC use is associated with excess risk of benign liver tumours, and a modest excess risk of liver cancer. The association with liver cancer was smaller for recent, low-dose OC. There was no evidence of an association between OC use and lung, digestive tract neoplasms other than colorectum, cutaneous malignant melanoma, thyroid cancer and any of the other neoplasms investigated.

Original languageEnglish
Pages (from-to)407-411
Number of pages5
JournalEuropean Journal of Cancer Prevention
Issue number5
Publication statusPublished - Sep 2009


  • Colorectal cancer
  • Cutaneous malignant melanoma
  • Liver cancers
  • Lung cancer
  • Oral contraceptives
  • Risk
  • Thyroid cancer

ASJC Scopus subject areas

  • Cancer Research
  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Oral contraceptives and neoplasms other than breast and female genital tract'. Together they form a unique fingerprint.

Cite this